Urogen Pharma Ltd
(URGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,211 | 101,571 | 37,197 | 21,457 | 17,996 |
| Marketable Securities | 97,389 | N/A | 36,001 | N/A | N/A |
| Receivables | N/A | N/A | N/A | 83 | N/A |
| Inventories | N/A | N/A | 316 | 105 | N/A |
| TOTAL | $148,634 | $102,243 | $74,472 | $22,041 | $19,131 |
| Non-Current Assets | |||||
| PPE Net | 977 | 948 | 805 | 741 | 259 |
| Investments And Advances | 48,555 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4,222 | 368 | 273 | 274 | 0 |
| TOTAL | $53,754 | $1,316 | $1,078 | $1,015 | $259 |
| Total Assets | $202,388 | $103,559 | $75,550 | $23,056 | $19,390 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,186 | 8,540 | 4,435 | 1,880 | 1,728 |
| Accrued Expenses | 6,711 | 4,925 | 1,950 | 687 | 509 |
| Other current liabilities | 1,585 | N/A | N/A | 570 | N/A |
| TOTAL | $19,482 | $13,465 | $7,035 | $3,137 | $2,237 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 650 | N/A | N/A |
| Other Non-Current Liabilities | 2,604 | 0 | 0 | 3,612 | 872 |
| TOTAL | $2,604 | $N/A | $N/A | $3,612 | $872 |
| Total Liabilities | $22,086 | $13,465 | $7,035 | $6,749 | $3,109 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,155 | N/A | N/A | N/A | N/A |
| Common Shares | 57 | 44 | 37 | 6 | 2 |
| Retained earnings | -228,017 | -122,871 | -47,214 | -27,214 | -25,273 |
| Other shareholders' equity | 276 | 0 | 0 | 0 | 0 |
| TOTAL | $180,302 | $90,094 | $68,515 | $16,307 | $16,281 |
| Total Liabilities And Equity | $202,388 | $103,559 | $75,550 | $23,056 | $19,390 |